Tag: Obstructive Sleep Apnea (OSA)
Researchers found Samsung Galaxy Watch accurately identifies sleep apnea
October 19, 2026HME News Staff
YARMOUTH, Maine – New research highlights the substantial potential of consumer-grade wearables to accurately detect moderate-to-severe sleep apnea using both apnea hypopnea index (AHI)- and hypoxic burden (HB)-defined risk strata across controlled and real-word settings. “The Samsung Galaxy Watch demonstrated high accuracy for detecting moderate-to-severe OSA and showed excellent performance for identifying individuals with high hypoxic burden, a subgroup at elevated cardiometabolic...
In brief: Resmed’s discontinuation, Samsung’s accuracy, RPM’s impact
October 16, 2026HME News Staff
SAN DIEGO – Resmed discontinued new sales of its Astral ventilator portfolio effective Sept. 14, 2026, according to a letter to customers.
The company says the decision allows it to prioritize available components and resources toward existing patients and continuity of care, following a field safety corrective action (FSCA).
“Ongoing supply constraints affecting critical electronic components have created significant challenges for the continued manufacture of Astral ventilators,”...
GLP-1s show promise as complement to CPAP for sleep apnea, researchers say
September 29, 2026HME News Staff
YARMOUTH, Maine – GLP-1 receptor agonists like tirzepatide are best used to treat obesity-related obstructive sleep apnea (OSA) alongside CPAP, according to a new abstract in JAMA Otolaryngology – Head & Neck Surgery. Researchers found that multiple studies showed the medications consistently reduced apnea-hypopnea index (AHI) scores, with the SURMOUNT-OSA trials reporting reductions of 20 to 24 events per hour and disease remission in 42% to 50% of patients. The drugs appear to work...
Daybreak joins Parachute Health, increasing access to therapy
September 1, 2026HME News Staff
LOS ANGELES – Daybreak has joined Parachute Health, creating a digital pathway that connects more than 300,000 clinicians and prescribers, 3,000 home medical equipment (HME) provider locations and 70,000 facilities and health systems nationwide using Parachute Health’s e-prescribing platform to Daybreak’s oral appliance therapy. "Obstructive sleep apnea remains widely underdiagnosed and undertreated in the United States, in part because the path from testing to treatment has...
Resmed signs NASCAR racer in new collab to raise awareness of sleep apnea
September 1, 2026HME News Staff
SAN DIEGO – Resmed has a new collaboration with 23XI Racing and its NASCAR Cup Series driver Tyler Reddick to encourage more people to recognize the signs of sleep apnea and seek diagnosis and treatment. After being diagnosed with obstructive sleep apnea (OSA) and starting continuous positive airway pressure (CPAP) therapy in early 2026, Reddick went on to become the first driver in NASCAR Cup Series history to open a season with three consecutive victories, which included the Daytona...
From data to diagnosis
August 21, 2026Dan Leonard
An estimated 1 billion people worldwide are living with obstructive sleep apnea (OSA), yet approximately 85% remain undiagnosed. This matters because undiagnosed OSA can significantly impact patients’ quality of life and increase the risk of other conditions like hypertension, heart disease and stroke. While these figures are staggering, innovations in consumer wearables are creating an opportunity to bridge this gap – not as a replacement for medical-grade diagnosis, but as a catalyst...
ReDream Brands debuts, combining four sleep-related businesses
August 17, 2026HME News Staff
NEW YORK – Cathay Capital has announced the launch of ReDream Brands, a new consumer health platform that brings together four direct-to-consumer brands: cpap.com, The CPAP Shop, Lofta and sleeping.com.
The launch follows a series of strategic transactions executed by Cathay Capital-backed cpap.com, including the formation of a joint venture with AdaptHealth bringing together cpap.com, sleeping.com, and The CPAP Shop, along with the subsequent acquisition of Lofta. The transactions were...
Daybreak expands access to oral appliance therapy for veterans
July 31, 2026Tracy Orzel
LOS ANGELES – For many veterans with obstructive sleep apnea (OSA), accessing oral appliance therapy (OAT) has often meant one more referral, one more appointment and one more barrier to care. Daybreak says its new distribution partnership with Veterans Healthcare Supply Solutions, a Service-Disabled Veteran Owned Small Business, changes all that.
Per the partnership, Daybreak is making its virtual OAT program available to VA health care facilities, military treatment facilities, the Department...
In brief: Prochant’s PE partner, CMS’s supplier suspensions, Samsung’s sleep expansion
July 17, 2026HME News Staff
CHARLOTTE, N.C. – Prochant has formed a strategic growth partnership with Longshore Capital Partners to expand its technology, services and operational capacity for home medical equipment (HME) and other home-based care providers.
"This partnership represents an important milestone for Prochant and a strong validation of the company our team has built," said Joey Graham, CEO of Prochant. "Longshore shares our conviction in the opportunity to combine deep revenue cycle expertise,...
Study links untreated OSA to faster cognitive decline
July 16, 2026HME News Staff
GAINESVILLE, Fla. - Older adults with untreated obstructive sleep apnea (OSA) experienced faster cognitive decline over 10 years than those treated with CPAP, according to a study published in Alzheimer’s & Dementia. Researchers analyzed 777 participants from the 2011 National Health and Aging Trends Study who had at least one Medicare claim for OSA and no cognitive impairment at baseline. CPAP treatment was defined as having one or more CPAP claims. The researchers tracked cognitive performance...